Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation during Endoscopic Submucosal Dissection: A Prospective, Randomized Controlled Study
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Propofol induced sedation with bispectral index (BIS) monitoring has been reported to lead to higher satisfaction in patients and endoscopists during endoscopic submucosal dissection (ESD) procedures. There are no data, however, regarding the effi cacy of midazolam and meperidine (M/M) induced sedation with BIS monitoring during ESD. The purpose of this study was to evaluate whether M/M induced sedation with BIS monitoring could improve satisfaction and reduce the dose of M/M required during ESD. Methods: Between September 2009 and January 2010, 56 patients were prospectively enrolled and randomly assigned to a BIS group (n=28) and a non-BIS group (n=28). Patient and endoscopist satisfaction scores were assessed using the visual analog scale (0 to 100) following the ESD. Results: The mean satisfaction scores did not significantly differ between the BIS and non-BIS groups (92.3±16.3vs 93.3±15.5, p=0.53) or endoscopists (83.1±15.4 vs 80.0±16.7, p=0.52). Although the mean meperidine dose did not differ (62.5±27.6 vs 51.0±17.3, p=0.18) between the two groups, the mean dose of midazolam in the non-BIS group was lower than in the BIS group (6.8±2.0 vs 5.4±2.1,p=0.01). Conclusions: BIS monitoring during ESD did not increase the satisfaction of endoscopists or patients and did not lead to an M/M dose reduction. These results demonstrate that BIS monitoring provides no additional benefi t to M/M induced sedation during ESD.
Abstract
Background/Aims: Propofol induced sedation with bispectral index (BIS) monitoring has been reported to lead to higher satisfaction in patients and endoscopists during endoscopic submucosal dissection (ESD) procedures. There are no data, however, regarding the effi cacy of midazolam and meperidine (M/M) induced sedation with BIS monitoring during ESD. The purpose of this study was to evaluate whether M/M induced sedation with BIS monitoring could improve satisfaction and reduce the dose of M/M required during ESD. Methods: Between September 2009 and January 2010, 56 patients were prospectively enrolled and randomly assigned to a BIS group (n=28) and a non-BIS group (n=28). Patient and endoscopist satisfaction scores were assessed using the visual analog scale (0 to 100) following the ESD. Results: The mean satisfaction scores did not significantly differ between the BIS and non-BIS groups (92.3±16.3vs 93.3±15.5, p=0.53) or endoscopists (83.1±15.4 vs 80.0±16.7, p=0.52). Although the mean meperidine dose did not differ (62.5±27.6 vs 51.0±17.3, p=0.18) between the two groups, the mean dose of midazolam in the non-BIS group was lower than in the BIS group (6.8±2.0 vs 5.4±2.1,p=0.01). Conclusions: BIS monitoring during ESD did not increase the satisfaction of endoscopists or patients and did not lead to an M/M dose reduction. These results demonstrate that BIS monitoring provides no additional benefi t to M/M induced sedation during ESD.
참고문헌 (28)
- Imagawa A, "Endoscopic submucosal dissection for early gastric cancer: results and degrees of technical difficulty as well as success", Endoscopy, 38, pp.987~990 (2006)
- Ono H, "Endoscopic mucosal resection for treatment of early gastric cancer", Gut, 48, pp.225~229 (2004)
- Ohkuwa M, "New endoscopic treatment for intramucosal gastric tumors using an insulated-tip diathermic knife", Endoscopy, 33, pp.221~226 (2001)
- Yahagi N, "Endoscopic submucosal dissection for early gastric cancer using the tip of an electrosurgical snare (thin type)", Dig Endosc, 16, pp.34~38 (2004)
- Johansen JW, "Development and clinical application of electroencephalographic bispectrum monitoring", Anesthesiology, 93, pp.1336~1344 (2000)
- Bower AL, "Bispectral index monitoring of sedation during endoscopy", Gastrointest Endosc, 52, pp.192~196 (2000)
- Struys M, "Moerman A, Rolly G. Clinical usefulness of the bispectral index for titrating propofol\ target effect-site concentration", Anaesthesia, 53, pp.4~12 (1998)
- Rosow C, "Bispectral index monitoring", Anesthesiol Clin North America, 19, pp.947~966 (2001)
- Glass PS, "Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers", Anesthesiology, 86, pp.836~847 (1997)
- Chen SC, "An initial investigation of bispectral monitoring as an adjunct to nurse-administered propofol sedation for colonoscopy", Am J Gastroenterol, 99, pp.1081~1086 (2004)
- Qadeer MA, "Bispectral index monitoring of conscious sedation with the combination of meperidine and midazolam during endoscopy", Clin Gastroenterol Hepatol, 6, pp.102~108 (2008)
- Drake LM, "Efficacy of bispectral monitoring as an adjunct to nurse-administered propofol sedation for colonoscopy: a randomized controlled trial", Am J Gastroenterol, 101, pp.2003~2007 (2006)
- DeWitt JM, "Bispectral index monitoring for nurse-administered propofol sedation during upper endoscopic ultrasound: a prospective, randomized controlled trial", Dig Dis Sci, 53, pp.2739~2745 (2008)
- Imagawa A, "Satisfaction with bispectral index monitoring of propofol-mediated sedation during endoscopic submucosal dissection: a prospective, randomized study", Endoscopy, 40, pp.905~909 (2008)
- American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists, "Practice guidelines for sedation and analgesia by non-anesthesiologists", Anesthesiology, 96, pp.1004~1017 (2002)
- Faigel DO, "Guidelines for the use of deep sedation and anesthesia for GI endoscopy", Gastrointest Endosc, 56, pp.613~617 (2002)
- Bell GD, "Preparation, premedication, and surveillance", Endoscopy, 36, pp.23~31 (2004)
- Lazzaroni M, "Preparation, premedication and surveillance", Endoscopy, 35, pp.103~111 (2003)
- Waring JP, "Guidelines for conscious sedation and monitoring during gastrointestinal endoscopy", Gastrointest Endosc, 58, pp.317~322 (2003)
- Chernik DA, "Validity and reliability of the Observer’s Assessment of Alertness", Sedation Scale: study with intravenous midazolam, 1990, pp.10, 244~251
- Bell GD, "Premedication, preparation, and surveillance", Endoscopy, 34, pp.2~12 (2002)
- Bryson HM, "Propofol: an update of its use in anaesthesia and conscious sedation", Drugs, 50, pp.513~599 (1995)
- Reimann FM, "Synergistic sedation with low-dose midazolam and propofol for colonoscopies", Endoscopy, 32, pp.239~244 (2000)
- Seifert H, "Sedation with propofol plus midazolam versus propofol alone for interventional endoscopic procedures: a prospective, randomized study", Aliment Pharmacol Ther, 14, pp.1207~1214 (2000)
- Jung M, "Improved sedation in diagnostic and therapeutic ERCP: propofol is an alternative to midazolam", Endoscopy, 32, pp.233~238 (2000)
- Hall RC, "Paradoxical reactions to benzodiazepines", Br J Clin Pharmacol, 11(Suppl 1), pp.99S~104S (1981)
- "Anesthesiology", 1997, A495~
- "Anesth Analg", 1997, S265~
